Stocks and Investing
Stocks and Investing
Tue, October 17, 2023
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Mon, October 16, 2023
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Mike Kratky Initiated (AXGN) at Buy and Held Target at $9 on, Oct 16th, 2023
Mike Kratky of Leerink Partners, Initiated "AxoGen, Inc." (AXGN) at Buy and Held Target at $9 on, Oct 16th, 2023.
Mike has made no other calls on AXGN in the last 4 months.
There are 2 other peers that have a rating on AXGN. Out of the 2 peers that are also analyzing AXGN, 0 agree with Mike's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Mike
- Ross Osborn of "Cantor Fitzgerald" Reiterated at Buy and Held Target at $16 on, Tuesday, September 26th, 2023
- Travis Steed of "Cantor Fitzgerald" Reiterated at Buy and Held Target at $16 on, Tuesday, August 22nd, 2023
Contributing Sources